Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy
    Kawamura, Yuichiro
    Satoh, Seiji
    Umeki, Yusuke
    Ishida, Yoshinori
    Suda, Koichi
    Uyama, Ichiro
    SPRINGERPLUS, 2016, 5
  • [2] Modified D2 gastrectomy: Is it justified in patients with advanced stage III gastric cancer?
    Nehra, D
    Evans, A
    Srivastava, ED
    Allison, MC
    Lewis, WG
    GASTROENTEROLOGY, 1998, 114 (04) : A653 - A653
  • [3] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
    Aoyama, Toru
    Yoshikawa, Takaki
    Hayashi, Tsutomu
    Kuwabara, Hiroshi
    Mikayama, Yo
    Ogata, Takashi
    Cho, Haruhiko
    Tsuburaya, Akira
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) : 1568 - 1574
  • [4] Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy
    Aoyama, Toru
    Yoshikawa, Takaki
    Shirai, Junya
    Fujikawa, Hirohito
    Hayashi, Tsutomu
    Ogata, Takashi
    Cho, Haruhiko
    Yukawa, Norio
    Oshima, Takashi
    Rino, Yasushi
    Masuda, Munetaka
    Tsuburaya, Akira
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [5] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
    Toru Aoyama
    Takaki Yoshikawa
    Tsutomu Hayashi
    Hiroshi Kuwabara
    Yo Mikayama
    Takashi Ogata
    Haruhiko Cho
    Akira Tsuburaya
    Annals of Surgical Oncology, 2012, 19 : 1568 - 1574
  • [6] Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?
    Feng, Qingbo
    Zhang, Tao
    Xie, Ming
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (05) : 2703 - 2704
  • [7] Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2
    Li, Yi-Fan
    Zhang, Wen-Bing
    Gao, Yu-Ye
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 15 (01): : 32 - 48
  • [8] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
    Shitara, Kohei
    Chin, Keisho
    Yoshikawa, Takaki
    Katai, Hitoshi
    Terashima, Masanori
    Ito, Seiji
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Tsujinaka, Toshimasa
    GASTRIC CANCER, 2017, 20 (01) : 175 - 181
  • [9] Tolerability of adjuvant chemotherapy with TS-1 or XELOX regimen in elderly patients with stage II or III gastric cancer after D2 gastrectomy
    Moon, H.
    Lee, H.
    Jeong, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S109 - S109
  • [10] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
    Kohei Shitara
    Keisho Chin
    Takaki Yoshikawa
    Hitoshi Katai
    Masanori Terashima
    Seiji Ito
    Motohiro Hirao
    Kazuhiro Yoshida
    Eiji Oki
    Mitsuru Sasako
    Yasunori Emi
    Toshimasa Tsujinaka
    Gastric Cancer, 2017, 20 : 175 - 181